{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T09:40:22Z","timestamp":1701337222619},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mdconsult.com","cardiology.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.ccl.2014.09.007","type":"journal-article","created":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T03:17:48Z","timestamp":1417231068000},"page":"49-57","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Contemporary Treatment of Venous Thromboembolic Disease"],"prefix":"10.1016","volume":"33","author":[{"given":"Taki","family":"Galanis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geno J.","family":"Merli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ccl.2014.09.007_bib1","doi-asserted-by":"crossref","first-page":"832.e13","DOI":"10.1016\/j.amjmed.2013.02.024","article-title":"Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE study cohort","volume":"126","author":"Tagalakis","year":"2013","journal-title":"Am J Med"},{"issue":"2 Suppl","key":"10.1016\/j.ccl.2014.09.007_bib2","doi-asserted-by":"crossref","first-page":"e351S","DOI":"10.1378\/chest.11-2299","article-title":"Diagnosis of DVT: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.ccl.2014.09.007_bib3","doi-asserted-by":"crossref","first-page":"578","DOI":"10.7326\/0003-4819-152-9-201005040-00008","article-title":"Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism","volume":"152","author":"Carrier","year":"2010","journal-title":"Ann Intern Med"},{"issue":"22","key":"10.1016\/j.ccl.2014.09.007_bib4","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa032274","article-title":"Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism","volume":"350","author":"Pengo","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ccl.2014.09.007_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archinte.164.1.17","article-title":"Relationship between deep venous thrombosis and the postthrombotic syndrome","volume":"164","author":"Kahn","year":"2004","journal-title":"Arch Intern Med"},{"issue":"2 Suppl","key":"10.1016\/j.ccl.2014.09.007_bib6","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ccl.2014.09.007_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003076.pub2","article-title":"Home versus in-patient treatment for deep vein thrombosis","author":"Othieno","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.ccl.2014.09.007_bib8","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1164\/rccm.200506-862OC","article-title":"Derivation and validation of a prognostic model for pulmonary embolism","volume":"172","author":"Aujesky","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"15","key":"10.1016\/j.ccl.2014.09.007_bib9","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/archinternmed.2010.199","article-title":"Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism","volume":"170","author":"Jimenez","year":"2010","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.ccl.2014.09.007_bib10","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1055\/s-0037-1614065","article-title":"Predicting adverse outcome in patients with acute pulmonary embolism: a risk score","volume":"84","author":"Wicki","year":"2000","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.ccl.2014.09.007_bib11","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.thromres.2009.09.026","article-title":"Home treatment in pulmonary embolism","volume":"126","author":"Otero","year":"2010","journal-title":"Thromb Res"},{"issue":"9785","key":"10.1016\/j.ccl.2014.09.007_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0140-6736(11)60824-6","article-title":"Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial","volume":"378","author":"Aujesky","year":"2011","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ccl.2014.09.007_bib13","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1183\/09031936.00133608","article-title":"Outpatient treatment and early discharge of symptomatic pulmonary embolism: a systematic review","volume":"33","author":"Squizzato","year":"2009","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ccl.2014.09.007_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002783.pub3","article-title":"Thrombolysis for acute deep vein thrombosis","author":"Watson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"16","key":"10.1016\/j.ccl.2014.09.007_bib15","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/CIR.0b013e318214914f","article-title":"Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association","volume":"123","author":"Jaff","year":"2011","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.ccl.2014.09.007_bib16","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1056\/NEJMoa021274","article-title":"Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism","volume":"347","author":"Konstantinides","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.ccl.2014.09.007_bib17","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa1302097","article-title":"Fibrinolysis for patients with intermediate-risk pulmonary embolism","volume":"370","author":"Meyer","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.ccl.2014.09.007_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001100.pub3","article-title":"Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism","author":"Erkens","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.ccl.2014.09.007_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003074.pub2","article-title":"Once versus twice daily LMWH for the initial treatment of venous thromboembolism","author":"van Dongen","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ccl.2014.09.007_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1477-9560-11-21","article-title":"Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies","volume":"11","author":"Prins","year":"2013","journal-title":"Thromb J"},{"issue":"7","key":"10.1016\/j.ccl.2014.09.007_bib21","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/CIRCULATIONAHA.113.004450","article-title":"Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis","volume":"129","author":"Schulman","year":"2014","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ccl.2014.09.007_bib22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/jth.12486","article-title":"Consistency of safety profile of new oral anticoagulants in patients with renal failure","volume":"12","author":"Lega","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"10.1016\/j.ccl.2014.09.007_bib23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archinternmed.2011.1666","article-title":"Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials","volume":"172","author":"Uchino","year":"2012","journal-title":"Arch Intern Med"},{"issue":"9920","key":"10.1016\/j.ccl.2014.09.007_bib24","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(13)61902-9","article-title":"Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial","volume":"383","author":"Kahn","year":"2014","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ccl.2014.09.007_bib25","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.thromres.2007.10.011","article-title":"Physical activity in patients with deep venous thrombosis: a systematic review","volume":"122","author":"Kahn","year":"2008","journal-title":"Thromb Res"},{"issue":"12","key":"10.1016\/j.ccl.2014.09.007_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008685.pub2","article-title":"Optimal loading dose of warfarin for the initiation of oral anticoagulation","author":"Mahtani","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"15","key":"10.1016\/j.ccl.2014.09.007_bib27","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/CIRCULATIONAHA.109.906347","article-title":"Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A","volume":"121","author":"Lijfering","year":"2010","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.ccl.2014.09.007_bib28","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1001\/jama.293.19.2352","article-title":"Thrombophilia, clinical factors, and recurrent venous thrombotic events","volume":"293","author":"Christiansen","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ccl.2014.09.007_bib29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1160\/TH08-06-0364","article-title":"High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin","volume":"101","author":"Brouwer","year":"2009","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.ccl.2014.09.007_bib30","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1538-7836.2009.03293.x","article-title":"Elevated D-dimer levels predict recurrence in patients with idiopathic venous thromboembolism: a meta-analysis","volume":"7","author":"Bruinstroop","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"issue":"8","key":"10.1016\/j.ccl.2014.09.007_bib31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.7326\/0003-4819-153-8-201010190-00009","article-title":"Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism","volume":"153","author":"Douketis","year":"2010","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.ccl.2014.09.007_bib32","doi-asserted-by":"crossref","first-page":"481","DOI":"10.7326\/0003-4819-149-7-200810070-00008","article-title":"Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism","volume":"149","author":"Verhovsek","year":"2008","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.ccl.2014.09.007_bib33","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/j.1538-7836.2004.00862.x","article-title":"Correlation between thrombus regression and recurrent venous thromboembolism. examining venographic and clinical effects of low-molecular-weight heparins: a meta-analysis","volume":"2","author":"Gomez-Outes","year":"2004","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"10.1016\/j.ccl.2014.09.007_bib34","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1538-7836.2011.04254.x","article-title":"Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta-analysis","volume":"9","author":"Carrier","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"10.1016\/j.ccl.2014.09.007_bib35","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1365-2141.2011.08578.x","article-title":"Residual venous thrombosis as predictive factor for recurrent venous thromboembolism in patients with proximal deep vein thrombosis: a systematic review","volume":"153","author":"Tan","year":"2011","journal-title":"Br J Haematol"},{"issue":"21","key":"10.1016\/j.ccl.2014.09.007_bib36","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa1114238","article-title":"Aspirin for preventing the recurrence of venous thromboembolism","volume":"366","author":"Becattini","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.ccl.2014.09.007_bib37","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJMoa1210384","article-title":"Low-dose aspirin for preventing recurrent venous thromboembolism","volume":"367","author":"Brighton","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2014.09.007_bib38","doi-asserted-by":"crossref","first-page":"f5133","DOI":"10.1136\/bmj.f5133","article-title":"Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis","volume":"347","author":"Castellucci","year":"2013","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ccl.2014.09.007_bib39","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/CIRCULATIONAHA.104.512834","article-title":"Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) Randomized Study","volume":"112","author":"PREPIC Study Group","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ccl.2014.09.007_bib40","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/CIRCULATIONAHA.105.592592","article-title":"Massive pulmonary embolism","volume":"113","author":"Kucher","year":"2006","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ccl.2014.09.007_bib41","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.amjmed.2011.05.025","article-title":"Impact of vena cava filters on in-hospital case fatality rate from pulmonary embolism","volume":"125","author":"Stein","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.ccl.2014.09.007_bib42","unstructured":"Removing retrievable inferior vena cava filters: initial communication. Available at: http:\/\/www.fda.gov\/MedicalDevices\/Safety\/AlertsandNotices\/ucm221676.htm. Accessed November 12, 2011."},{"issue":"4","key":"10.1016\/j.ccl.2014.09.007_bib43","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.surg.2009.06.022","article-title":"Institutional protocol improves retrievable inferior vena cava filter recovery rate","volume":"146","author":"Ko","year":"2009","journal-title":"Surgery"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865114000940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865114000940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T23:09:31Z","timestamp":1566083371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865114000940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0733865114000940"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2014.09.007","relation":{},"ISSN":["0733-8651"],"issn-type":[{"value":"0733-8651","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contemporary Treatment of Venous Thromboembolic Disease","name":"articletitle","label":"Article Title"},{"value":"Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccl.2014.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}